/ Blog / Sol-Gel Acquires FDA Approval For Its Encapsulated Skin Disease Drug


06 May 2022

Sol-Gel Acquires FDA Approval For Its Encapsulated Skin Disease Drug

Sol-Gel Technologies is one of the most well-reputable names for developing innovative and safe medications for skin diseases. The dermatology organization specializes in recognizing, creating, and commercialising generic and branded topical drugs and drug products to treat a plethora of skin diseases. It partnered with Galderma and started creating an encapsulated drug, EPSOLAY, for Rosacea.


What Is Rosacea?


Rosacea is a significantly common skin disease that results in quick flushing, blushing, and prominent blood vessels appearing on your face. It can even cause pus-filled bumps, both small and big. While the signs start appearing immediately, they take ample time to disappear and heal completely. Apart from pimple-like breakouts, other common symptoms of this skin disease include eye issues and thickened skin.


Treatment Options For Rosacea 


Previously, the primary treatment for Rosacea included a range of antibiotic gels that were to be applied gently across the affected skin patches. They kill mites or bacteria that may be causing Rosacea. But even then, the cure isn’t permanent, and people with Rosacea can, at best, try to manage the bumpy pores and redness slightly better. Once healed in a span of weeks to months, the redness will reappear eventually.


In addition, patients would also require maintaining dry-skin-skincare routines to avoid triggering Rosacea and change their lifestyles, including reducing exposure to sunlight, extreme temperatures, stress, or spicy foods.


EPSOLAY By Sol-Gel And Galderma 


Recently, Sol-Gel initiated a project to launch an encapsulated drug to treat Rosacea. The formula includes using microencapsulation technology for benzoyl peroxide and silica-based shells. It limits the patient’s skin exposure to active triggers and ingredients causing the skin disease. Moreover, the drug is also said to eliminate and avoid skin irritation- a critical and discomforting Rosacea symptom.


It was announced in April 2022 that FDA had approved EPSOLAY, permitting Galderma to begin its sales and promotional activities in the United States. The approval procedure consisted of pair 3 clinical trials to evaluate the effectiveness of the medication and whether it was more successful than a placebo. Trials ran for twelve weeks, after which observations found EPSOLAY better than placebo at improving the disease scale scores and diminishing inflammatory lesions. The inflammations due to Rosacea decreased by more than 70% during the twelve-week trials.


The Way Ahead 


Sol-Gel had filed for the encapsulated drug’s patent, and the formula is now patent-protected till 2040, offering the creator’s benefits to the dermatology company. With EPSOLAY set to be commercialised in US markets under an exclusive license soon, all that’s left is assessing the consumer interest in buying and using the product.


Both companies are looking forward to exemplary positive results. Alon Seri-Levy, Ph.D. and CEO of Sol-Gel, calls EPSOLAY a “watershed moment for the sixteen million US locals suffering from Rosacea.” The drug’s entry into the market may only be limited to the United States at the moment. However, gaining a reputation and increasing demands with expanding supply chains can soon bring the drug into global markets.

Share on

Continue Reading

Five Biggest Scented-Candle Manufacturers Worldwide

Scented candles are soothing, rejuvenating, and relaxing creations commonly used for their pleasant and aromatic after-scent.

Leading Electric Vehicle Producers

It’s no shocker that electric vehicles are the next big thing. In fact, they are the big thing- because there’s no next to electric vehicles. They’re the present and future, both. EVs are taking the world by storm with their rapid demand levels, super-advanced features, ultra-elegant appeal, and, most importantly: their premium eco-friendliness.

A Shift in the Global Dental Imaging Systems Market

The global dental imaging systems market is segmented based on types, consumers, and applications. The types of dental imaging include digital sensors, intraoral x-rays, extraoral X-rays, and Hybrid X-ray systems.

Collagen Market - Know all about the trends

Collagen is the most abundant protein in the human body and is found in all connective tissues, bones and muscles. This fibrous protein makes up about the majority of skin, tendon and bone dry weight. It's also responsible for keeping skin plump, flexible and youthful looking.

Recent Press Releases

Cholesterol Tests Market Research Reports Now on Douglas Insights Comparison Engine

The cholesterol test market is rapidly growing worldwide. The industry is segmented by product type, test type, and region. Product type includes testing str...

Douglas Insights Adds Compostable Foodservice Packaging Market Research Reports to Its ...

Douglas Insights, one of the world's first comparison tools, has updated its database to reflect the market's prospects, advancements, driving factors, proje...

Douglas Insights Adds AI-based Clinical Trials Solution Provider Market Research Report...

Douglas Insights has further expanded its comparison engine with AI-based Clinical Trials Solution Provider Market research reports, allowing market research...

Douglas Insights Adds Fuel Cells Market Research Reports to Its Comparison Engine

Douglas Insights has analysed various aspects of the Fuel Cells Market and revealed the changes in market trends due to increased awareness of climate change...